BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26788508)

  • 81. The association between fibroblast growth factor receptor 1 gene amplification and lung cancer: a meta-analysis.
    Miao JL; Zhou JH; Cai JJ; Liu RJ
    Arch Med Sci; 2020; 16(1):16-26. PubMed ID: 32051701
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells.
    Zhang PF; Pei X; Li KS; Jin LN; Wang F; Wu J; Zhang XM
    Mol Cancer; 2019 Dec; 18(1):179. PubMed ID: 31815619
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Algorithm for the treatment of advanced or metastatic squamous non-small-cell lung cancer: an evidence-based overview.
    Daaboul N; Nicholas G; Laurie SA
    Curr Oncol; 2018 Jun; 25(Suppl 1):S77-S85. PubMed ID: 29910650
    [TBL] [Abstract][Full Text] [Related]  

  • 84. FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.
    Flockerzi FA; Roggia C; Langer F; Holleczek B; Bohle RM
    Virchows Arch; 2018 May; 472(5):759-769. PubMed ID: 29270870
    [TBL] [Abstract][Full Text] [Related]  

  • 85. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.
    Chen B; Liu S; Gan L; Wang J; Hu B; Xu H; Tong R; Yang H; Cristina I; Xue J; Hu X; Lu Y
    Cancer Biol Ther; 2018 Jan; 19(1):76-86. PubMed ID: 29257923
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer.
    Michael M; Bang YJ; Park YS; Kang YK; Kim TM; Hamid O; Thornton D; Tate SC; Raddad E; Tie J
    Target Oncol; 2017 Aug; 12(4):463-474. PubMed ID: 28589492
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
    Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
    World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data.
    Wang Y; Gao W; Xu J; Chen X; Yang Y; Zhu Y; Yin Y; Guo R; Liu P; Shu Y; Liu L
    Biomed Res Int; 2015; 2015():763080. PubMed ID: 26788508
    [TBL] [Abstract][Full Text] [Related]  

  • 89. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.
    Seo AN; Jin Y; Lee HJ; Sun PL; Kim H; Jheon S; Kim K; Lee CT; Chung JH
    Virchows Arch; 2014 Nov; 465(5):547-58. PubMed ID: 25086725
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
    J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
    [TBL] [Abstract][Full Text] [Related]  

  • 91. FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis.
    Jiang T; Gao G; Fan G; Li M; Zhou C
    Lung Cancer; 2015 Jan; 87(1):1-7. PubMed ID: 25433983
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer.
    Miao JL; Liu RJ; Zhou JH; Meng SH
    Chin Med J (Engl); 2016 Dec; 129(23):2868-2872. PubMed ID: 27901003
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
    Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
    Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.